Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Συντάκτης Τίτλος [ Τύπος(Asc)] Έτος
Journal Article
Karamitsos, T. D., & Neubauer S. (2011).  Cardiovascular magnetic resonance in heart failure.. Curr Cardiol Rep. 13(3), 210-9.
Mavrogeni, S., Markousis-Mavrogenis G., Koutsogeorgopoulou L., Dimitroulas T., Bratis K., Kitas G. D., et al. (2017).  Cardiovascular magnetic resonance imaging pattern at the time of diagnosis of treatment naïve patients with connective tissue diseases.. Int J Cardiol. 236, 151-156.
Ntusi, N. A. B., Francis J. M., Gumedze F., Karvounis H., Matthews P. M., Wordsworth P. B., et al. (2019).  Cardiovascular magnetic resonance characterization of myocardial and vascular function in rheumatoid arthritis patients.. Hellenic J Cardiol. 60(1), 28-35.
Repanas, T. I., Papanastasiou C. A., Efthimiadis G. K., Fragkakis N., Sachpekidis V., Klein R. Michael, et al. (2020).  Cardiovascular magnetic resonance as a complementary method to transthoracic echocardiography for aortic valve area estimation in patients with aortic stenosis: A systematic review and meta-analysis.. Hellenic J Cardiol.
Karamitsos, T. D., & Neubauer S. (2011).  Cardiovascular magnetic resonance: a powerful diagnostic and prognostic tool in modern cardiology.. Prog Cardiovasc Dis. 54(3), 179-80.
Chang, Y-J., Chang S-L., Chong E., Suenari K., & Michalopoulos A. (2017).  Cardiovascular Emergencies.. Biomed Res Int. 2017, 7210261.
Papagianni, M., & Tziomalos K. (2015).  Cardiovascular effects of dipeptidyl peptidase-4 inhibitors.. Hippokratia. 19(3), 195-9.
Sarafidis, P. A., & Bakris G. L. (2015).  Cardiovascular disease in CKD in 2014: new insights into cardiovascular risk factors and outcomes.. Nat Rev Nephrol. 11(2), 70-2.
Kostopoulou, E., Bosdou J. K., Anagnostis P., Stevenson J. C., & Goulis D. G. (2020).  Cardiovascular complications in patients with Turner's syndrome.. Curr Pharm Des.
Athyros, V. G., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2011).  Cardiovascular benefits of bariatric surgery in morbidly obese patients.. Obes Rev. 12(7), 515-24.
Zarogoulidis, P., Tsakiridis K., Kioumis I., & Zarogoulidis K. (2014).  Cardiothoracic diseases: basic treatment.. J Thorac Dis. 6 Suppl 1, S1.
Kadoglou, N. P. E., Iliadis F., Angelopoulou N., Sailer N., Fotiadis G., Voliotis K., et al. (2009).  Cardiorespiratory capacity is associated with favourable cardiovascular risk profile in patients with Type 2 diabetes.. J Diabetes Complications. 23(3), 160-6.
Pagourelias, E. D., Koumaras C., Kakafika A. I., Tziomalos K., Zorou P. G., Athyros V. G., et al. (2009).  Cardiorenal anemia syndrome: do erythropoietin and iron therapy have a place in the treatment of heart failure?. Angiology. 60(1), 74-81.
Deliliga, A., Chatzinikolaou F., Koutsoukis D., Chrysovergis I., & Voultsos P. (2019).  Cardiopulmonary resuscitation (CPR) complications encountered in forensic autopsy cases.. BMC Emerg Med. 19(1), 23.
Boutou, A. K., Daniil Z., Pitsiou G., Papakosta D., Kioumis I., & Stanopoulos I. (2020).  Cardiopulmonary exercise testing in patients with asthma: What is its clinical value?. Respir Med. 167, 105953.
Rezaee, R., Sheidary A., Jangjoo S., Ekhtiary S., Bagheri S., Kohkan Z., et al. (2019).  Cardioprotective effects of hesperidin on carbon monoxide poisoned in rats.. Drug Chem Toxicol. 1-6.
Kanashiro-Takeuchi, R. M., Tziomalos K., Takeuchi L. M., Treuer A. V., Lamirault G., Dulce R., et al. (2010).  Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction.. Proc Natl Acad Sci U S A. 107(6), 2604-9.
Antonitsis, P., Ioannidou-Papagiannaki E., Kaidoglou A., Charokopos N., Kalogeridis A., Kouzi-Koliakou K., et al. (2008).  Cardiomyogenic potential of human adult bone marrow mesenchymal stem cells in vitro.. Thorac Cardiovasc Surg. 56(2), 77-82.
Chourdakis, M., Panayiotoglou A., Grammatikopoulou M. G., Theodoridis X., Gkiouras K., Maraki M. I., et al. (2018).  Cardiometabolic disease staging system in retired professional soccer players.. Clin Nutr ESPEN. 24, 177.
Kountouras, J., Polyzos S. A., Katsinelos P., Zeglinas C., Artemaki F., Tzivras D., et al. (2017).  Cardio-cerebrovascular disease and Helicobacter pylori-related metabolic syndrome: We consider eradication therapy as a potential cardio-cerebrovascular prevention strategy.. Int J Cardiol. 229, 17-18.
Mavrogeni, S. I., Sfikakis P. P., Koutsogeorgopoulou L., Markousis-Mavrogenis G., Dimitroulas T., Kolovou G., et al. (2017).  Cardiac Tissue Characterization and Imaging in Autoimmune Rheumatic Diseases.. JACC Cardiovasc Imaging. 10(11), 1387-1396.
Tsaousi, G., Stazi E., Cinicola M., & Bilotta F. (2018).  Cardiac output changes after osmotic therapy in neurosurgical and neurocritical care patients: a systematic review of the clinical literature. British Journal of Clinical Pharmacology. 841731195917419801050713327943391735534334307422417218078681232928286461521163981101071(4), 636 - 648.
Ibanez, B., Aletras A. H., Arai A. E., Arheden H., Bax J., Berry C., et al. (2019).  Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials: JACC Scientific Expert Panel.. J Am Coll Cardiol. 74(2), 238-256.
Ibanez, B., Aletras A. H., Arai A. E., Arheden H., Bax J., Berry C., et al. (2019).  Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials. Journal of the American College of Cardiology. 74(2), 238 - 256.
Papadopoulou-Legbelou, K., Gogou M., & Evangeliou A. (2017).  Cardiac Manifestations in Children with Inborn Errors of Metabolism.. Indian Pediatr. 54(8), 667-673.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές